Skip to main navigation Skip to search Skip to main content

The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients

  • Ronit Grinbaum*
  • , Aviram Nissan
  • , Nahum Beglaibter
  • , Tzeela Cohen
  • , Tamar Peretz
  • , Herbert R. Freund
  • *Corresponding author for this work
  • Hadassah University Medical Centre

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Carbohydrate antigen (CA) 19-9 is produced by adenocarcinomas of the pancreas, stomach, gall bladder, colon, ovary and lung. Serum CA 19-9 is considered the most sensitive marker for pancreatic cancer, being elevated in 75% or more of patients with pancreatic cancer. In all three cases of pancreatic cancer presented, patients died of their disease quite shortly after diagnosis. Preoperative imaging was unsuccessful in exposing the actual advanced state extent of the disease and even during surgery its real extent was underestimated. The only prognostic indicator of the observed rapid disease progression was a very significant elevation of preoperative serum CA 19-9.

Original languageEnglish
Pages (from-to)793-794+863
JournalHarefuah
Volume145
Issue number11
StatePublished - Nov 2006
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CA-19-9 surgery
  • Pancreatic cancer
  • Survival

Fingerprint

Dive into the research topics of 'The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients'. Together they form a unique fingerprint.

Cite this